ClinicalTrials.gg
Sign In
Status unknownNCT03273179Updated Feb 5, 2018

Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales

An observational study in Cerebral Venous Sinus Thrombosis, CSF Pressure Increased and Papilledema, sponsored by Capital Medical University. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2018-02-05.

Sponsored by Capital Medical University · Observational

The sponsor has not verified this record recently (last verified Feb 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
100
Sex
All
01

Study summary

This is a single-center, retrospective, open-label study. This study is planned to investigate the accuracy of mRS and NIHSS, comparing with the accuracy of CSF pressure and papilledema grade in assessing cerebral venous sinus thrombosis.

02

Conditions studied

  • Cerebral Venous Sinus Thrombosis
  • CSF Pressure Increased
  • Papilledema

Keywords

  • cerebral venous sinus thrombosis
  • CSF pressure
  • modified Rankin Scale
  • papilledema
  • NIHSS
03

In context

Intracranial Hypertension

165 studies on the registry are indexed under Intracranial Hypertension; 36 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 76 observational studies indexed under Intracranial Hypertension.

Browse Intracranial Hypertension studies →

Lead sponsor

Capital Medical University is the lead sponsor of 295 studies on the registry; 91 are open to participants now.

Browse Capital Medical University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All individual with confirmed diagnosis of CVST are eligible for this research

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • confirmed diagnosis of CVST by head MRI, DSA or MRV onset of CVST within one month

Exclusion criteria

Exclusion Criteria:

  • unable to complete examinations unable to complete follow-ups
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. baseline CSF pressure

    CSF pressure at baseline

    Time frame: baseline

  2. baseline mRS

    mRS at baseline

    Time frame: baseline

  3. baseline papilledema grade

    Frisen grade of papilledema at baseline

    Time frame: baseline

Secondary outcomes

  1. baseline NIHSS

    NIH Stroke Scale at baseline

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
  • Xuanwu Hospital Capital Medical University
    Beijing, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2017 (actual). Primary completion is estimated for Apr 2018, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2017
First posted
Sep 6, 2017
StartActual
Jun 1, 2017
Primary completionEst.
Apr 1, 2018
CompletionEst.
Jul 1, 2018
Last update
Feb 5, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03273179
Lead sponsor
Capital Medical University
Responsible party
Ji Xunming (Professor, Capital Medical University) — Principal investigator
First posted
Sep 6, 2017
Start date
Jun 1, 2017
Primary completion
Apr 1, 2018 (estimated)
Completion
Jul 1, 2018 (estimated)
Last update
Feb 5, 2018

Study contacts

Xunming Ji
Contact
jixunming@vip.163.com
+86-83198952
Zhen Zhang
Contact
gzhenzhang@sina.com

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Intracranial Hypertension →

Other studies from this sponsor

Capital Medical University →

Start the discussion